Showing results (91-100 of 340) with videos related to
Sort By:
Pageof 34
The Canadian Journal of Urology|April 25, 2017
Quantification of risk factors in 500 patients with postoperative urinary retentionPeter N Tsambarlis, Benjamin A Sherer, Karl F Godlewski, et al.The Laryngoscope|April 27, 2011
STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspiratesMihir R Patel, Michael E Stadler, Allison M Deal, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 12, 2011
Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinomaAllison M Deal, Mihir R Patel, Brian D Thorp, et al.Translational Behavioral Medicine|August 8, 2018
Implementing a small media intervention to increase colorectal cancer screening in primary care clinicsCathy L Melvin, Anissa I Vines, Allison M Deal, et al.Journal of Geriatric Oncology|August 23, 2018
Inflammatory markers and overall survival in older adults with cancerTomohiro F Nishijima, Allison M Deal, Jennifer L Lund, et al.Journal of Medical Internet Research|December 23, 2018
Acknowledgment Correction of: Impact of Game-Inspired Infographics on User Engagement and Information Processing in an eHealth ProgramMaria Leonora G Comello, Xiaokun Qian, Allison M Deal, et al.Cancer|September 17, 2013
To preserve or not to preserve: how difficult is the decision about fertility preservation?Jennifer E Mersereau, Linnea R Goodman, Allison M Deal, et al.Psycho-Oncology|February 7, 2015
An exploratory study of end-of-life prognostic communication needs as reported by widowed fathers due to cancerEliza M Park, Devon K Check, Justin M Yopp, et al.Journal of Surgical Oncology|February 10, 2015
Prognostic significance of tumor mitotic rate in T2 melanoma staged with sentinel lymphadenectomyJustin J Baker, Michael O Meyers, Allison M Deal, et al.Journal of Geriatric Oncology|April 23, 2022
Age and competing concerns in treatment selection for women with non-metastatic HR+ and HER2- breast cancer: Current clinical practiceMichael K Lorentsen, Sanah Vohra, Hyman B Muss, et al.Pageof 34